USPTO Patent Applications - Organic Chemistry (C07D)

Chromophores with New Bridges that Increase Refractive Index

The USPTO has published a patent application (US20260085236A1) for Lightwave Logic, Inc., detailing new nonlinear optical (NLO) chromophores designed to increase refractive index. These chromophores offer improved electro-optic effects, modulation speed, photostability, and thermal stability, making them suitable for low-power, small-footprint electro-optic devices.

Patent Application for Artemisinic Acid Derivative Preparation

The USPTO has published a patent application (US20260085030A1) for an artemisinic acid derivative and its preparation method. The application, filed by Yunnan Botanee Bio-Technology Group Co., Ltd., aims to improve the water solubility of artemisinic acid and dihydroartemisinic acid while retaining their whitening, anti-inflammatory, and anti-tumor properties.

Patent Application for GYS1 Inhibitors

The USPTO has published a patent application (US20260085034A1) for N-(BENZHYDRYL)CYCLOALKYLCARBOXAMIDE derivatives as inhibitors of Glycogen Synthase 1 (GYS1). The application details compounds and methods for preparing them, as well as methods for inhibiting GYS1 and treating GYS1-mediated diseases.

Novel Nootropic Prodrugs of Phenethylamine

The USPTO has published a patent application (US20260085036A1) for novel nootropic prodrugs of phenethylamine, assigned to MiHKAL GmbH. The application describes compounds designed to improve phenethylamine uptake and reduce side effects, potentially for treating conditions like depression and PTSD.

Psilocin Crystalline Forms Patent Application

The USPTO has published a patent application (US20260085039A1) detailing crystalline forms of psilocin, including salts and cocrystals. The application, filed by Jim Gilligan and Peter Guzzo, describes these forms as having improved physical properties like aqueous solubility and stability, suitable for various administration routes.

Patent Application for Psilocin Derivatives for Treating Disorders

The USPTO has published a patent application (US20260085040A1) for psilocin derivatives, including carbohydrate and amino acid conjugates. These compounds are intended for the treatment of various neuropsychiatric, neurodegenerative, neuroinflammatory, and pain disorders.

Patent Application for Chromophores with New Ring-Locked Donors

The USPTO has published a new patent application (US20260085189A1) filed by Lightwave Logic, Inc. The application describes novel nonlinear optical (NLO) chromophores with ring-locked donors designed to increase r33 and stability. The filing date was September 23, 2025.

Patent Application for NLO Chromophores with New Acceptors

The USPTO has published a patent application (US20260085190A1) filed by Lightwave Logic, Inc. The application describes nonlinear optical (NLO) chromophores designed to increase refractive index, offering advantages in speed, photostability, and thermal stability for electro-optic devices.

Photoresist Molecular Group Structure, Synthesis, and Use Method

The USPTO has published a new patent application (US20260086460A1) for a bifunctional molecular group structure for photoresists, including a linker, PAG molecule, and PDQ molecule. The application also details synthesis and use methods for this structure, assigned to Shanghai Huali Integrated Circuit Corporation.

US Patent Application: Non-Aqueous Electrolyte, Battery, Device

The USPTO has published a new patent application (US20260088357A1) for a non-aqueous electrolyte, secondary battery, and electric device. The application, filed by CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED, details specific chemical compositions for electrolytes, including cyclic sulfate compounds and organic base additives. This publication represents a new disclosure in the field of battery technology.

Patent for Heterocyclic Compound Organic Light Emitting Device

The USPTO has published a patent application for a heterocyclic compound intended for use in organic light-emitting devices. The application, filed by Eui-Jeong Choi and others, describes a compound that may improve device efficiency and lifespan.

Patent Application: Organic Light Emitting Device Compound

The USPTO has published a new patent application, US20260090199A1, detailing a novel organic compound for use in organic light-emitting devices. The application describes a compound that may offer improved driving voltage, efficiency, and service life compared to existing technologies.

Mitsubishi Gas Chemical Organic Thin Film Patent Application

The USPTO has published a new patent application from Mitsubishi Gas Chemical Company, Inc. for a compound and organic thin film technology. The application, filed on December 14, 2023, details a specific molecular structure intended for use in photoelectric conversion elements and imaging devices.

Organic Compound and Light-Emitting Device Patent Application

The USPTO has published a patent application (US20260090268A1) for an organic compound and a light-emitting device incorporating it. The application details specific chemical structures and their application in electronic apparatus. The filing date was September 8, 2025.

Organic electronic element and compound for improved hole transport

The USPTO has published a new patent application, US20260090270A1, filed by TOSOH CORPORATION. The application describes an organic electronic element and a compound designed to improve hole transport ability, potentially enhancing performance in electronic devices.

Lamotrigine Salts, Co-crystals, and Compositions Patent Application

The USPTO has published a patent application (US20260083745A1) for lamotrigine oral suspension and its preparation method, filed by Azurity Pharmaceuticals Ireland Limited. The application details a formulation designed to improve the stability and redispersibility of lamotrigine suspensions.

Patent Application: 7-Cyano-8-Hydroxyquinoline Derivative Medical Use

The USPTO has published a patent application for a 7-cyano-8-hydroxyquinoline derivative, its preparation method, and its medical use in treating infectious diseases or cancer. The application details a compound with potential antibacterial, antiviral, and antitumor activity.

USPTO Patent Application: Organic Electroluminescent Materials and Devices

The USPTO has published a patent application by Universal Display Corporation for organic electroluminescent materials and devices. The application details organometallic compounds, formulations, and organic light emitting devices (OLEDs) utilizing these compounds.

USPTO Patent Application for Organic Light-Emitting Device Compound

The USPTO has published a patent application (US20260082806A1) for a new compound and an organic light-emitting device incorporating it. The application details a compound of Chemical Formula 1, which may offer low driving voltage, high light emitting efficiency, or a long service life.

USPTO Patent Application for Organic Optoelectronic Device Compound

The USPTO has published a patent application (US20260082808A1) detailing a new compound and composition for organic optoelectronic devices and display devices. The application was filed on September 8, 2025, and published on March 19, 2026.

USPTO Patent Application: Heterocyclic Compound for Organic Light Emitting Devices

The USPTO has published a patent application detailing a novel heterocyclic compound for use in organic light-emitting devices (OLEDs). The application, filed by inventors from South Korea, claims improvements in driving voltage, light emission efficiency, and device lifetime.

USPTO Patent Application: Light Emitting Element and Polycyclic Compound

The USPTO has published a patent application for a novel polycyclic compound and a light emitting element that includes it. The application, filed on November 19, 2025, aims to improve luminous efficiency in light emitting devices.